| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ENVUE MEDICAL Aktie jetzt für 0€ handeln | |||||
| Di | ENvue Medical, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 29.10. | ENvue Medical Commences U.S. Production of UroShield and Begins Fulfilling UK Distributor Orders | 457 | ACCESS Newswire | Shipments to Peak Medical underway under agreement with multi-million-dollar minimum purchase commitments through 2029; follows September start of PainShield shipments in the U.S. ARLINGTON HEIGHTS... ► Artikel lesen | |
| 26.10. | ENvue Medical Issues Letter to Shareholders | 323 | ACCESS Newswire | Letter Highlights Inova Clinical Data, Hospital Customer Base and Leaner Operating Structure ARLINGTON HEIGHTS, IL / ACCESS Newswire / October 26, 2026 / ENvue Medical, Inc. (OTC PINK:FEED) ("ENvue... ► Artikel lesen | |
| 14.10. | ENvue Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.09. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.09.2026 | 595 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 24.09.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.09.2026ISIN NameCA60686A4090 MKANGO... ► Artikel lesen | |
| 16.09. | Envue Medical (FEED) Shares Fall 23% After Hours: Here's What Is Going On | 4 | Benzinga.com | ||
| 15.09. | ENvue Medical, Inc.: ENvue Medical Provides Nasdaq Listing Update | 252 | GlobeNewswire (Europe) | TYLER, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (Nasdaq: FEED) ("ENvue" or the "Company"), a medical technology company focused on innovative solutions for enteral feeding and... ► Artikel lesen | |
| 09.09. | ENvue Medical resumes PainShield shipments from U.S. facility | 1 | Investing.com | ||
| 02.09. | ENvue Medical, Inc.: ENvue Medical Selected to Exhibit ENvue Navigation Platform at Vizient Innovative Technology Exchange | 1 | GlobeNewswire (USA) | ||
| 01.09. | XFRA 56R: AUSSETZUNG/SUSPENSION | 313 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILENVUE MED INC. NEW... ► Artikel lesen | |
| 01.09. | XFRA NEW INSTRUMENTS AVAILABLE ON 01.09.2026 | 280 | Xetra Newsboard | The following instruments on XETRA do have their first trading 01.09.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 01.09.2026
Aktien
1 VGG863021256 SWVL Holdings Corp.
2... ► Artikel lesen | |
| 31.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 31.08.2026 | 797 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 31.08.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 31.08.2026ISIN NameDE000A0N3UD5 ROSTRA... ► Artikel lesen | |
| 31.08. | XFRA ISIN CHANGE | 286 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS63008J8844 ENvue Medical Inc. 31.08.2026 US63008J8760 ENvue Medical Inc. 01.09.2026 Tausch 12:1 ► Artikel lesen | |
| 28.08. | ENvue Medical announces 1-for-12 reverse stock split | 6 | Investing.com | ||
| 28.08. | ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split | 267 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that a reverse stock split... ► Artikel lesen | |
| 19.08. | ENvue Medical: Revenue Jumps 275% As Hospital Adoption Offsets PainShield Production Shutdown | 5 | pulse2.com | ||
| 18.08. | ENvue Medical, Inc.: ENvue Medical Announces Exclusive UroShield Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million | 259 | GlobeNewswire (Europe) | TYLER, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical device company, today announced a new exclusive distribution agreement... ► Artikel lesen | |
| 17.08. | ENvue Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.08. | ENvue Medical secures up to $50M equity facility to fund growth plans | 3 | Seeking Alpha | ||
| 12.08. | ENvue Medical secures $50M equity financing facility | 5 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,420 | -0,91 % | Siemens Healthineers Aktie: Zwischen Übergangsjahr und Kursfantasie | Die Analysten sind sich nach den jüngsten Quartalszahlen von Siemens Healthineers uneinig über die weiteren Perspektiven der Aktie. Während Jefferies nach der Erholung im Geschäft mit medizinischer... ► Artikel lesen | |
| TELADOC HEALTH | 6,976 | -1,91 % | Truist raises Teladoc stock price target to $9 on EBITDA outlook | ||
| BECTON DICKINSON | 194,15 | +0,18 % | BD eyes deeper cooperation as China's medical innovation advances | ||
| SERNOVA BIOTHERAPEUTICS | 0,059 | 0,00 % | Sernova Biotherapeutics: 11,2 Millionen Dollar für die Fusion - und doch rutscht die Aktie | ||
| CERENOME | 0,541 | -7,52 % | Cerenome outlines $10M-$12.5M 2026 gross billings run rate exit while targeting mid-2027 REYOBIQ top line data | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Medical Devices Provides Update on Health Canada Licence Application | Toronto, Ontario--(Newsfile Corp. - November 13, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a developer of needle-free drug delivery technology, provides an update regarding... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,570 | -2,48 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SPINEWAY | 0,095 | +10,85 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Rekord bei Umsatz und Gewinn - lächerliche Bewertung! | Sonoma Pharmaceuticals macht den nächsten gewaltigen Schritt auf dem Weg zum profitablen Wachstumsunternehmen. Nach dem erstmaligen Erreichen eines positiven EBITDA im Vorquartal meldet der Healthcare-Spezialist... ► Artikel lesen | |
| TANDEM DIABETES | 15,500 | +0,65 % | Warum die Aktie von Tandem Diabetes Care heute kräftig zulegt | ||
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| CO-DIAGNOSTICS | 0,163 | -1,22 % | Co-Diagnostics Announces Reverse Stock Split | SALT LAKE CITY, Nov. 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Diagnostics" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| QUIDELORTHO | 8,994 | +10,74 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,110 | 0,00 % | Veru presents data on enobosarm for obesity treatment | ||
| LIFEWARD | 2,930 | 0,00 % | Lifeward GAAP EPS of -$1.32 misses by $0.50, revenue of $5.43M misses by $1.81M |